KALRN and congenital secretory chloride diarrhea 1: Over five years, DuO testing could save $236M in direct medical costs for a cohort of 100,000 patients with CLD due to reduction in EGDs as well as clinical follow-up and testing in those with DSI ≤18.3 and improved adherence to SOC guidelines for DSI >18.3 patients.